摘要
目的 探讨不同化疗方案对治疗晚期非小细胞肺癌 (nSCLC)的经济效果。方法 根据文献选择 93例晚期肺小细胞肺癌患者 ,分为 3组 ,分别给予IVP (异环磷酰胺、长春地辛、顺铂 )、MVP (丝裂霉素、长春地辛、顺铂 )和CAP (环磷酰胺、阿霉素、顺铂 )方案进行化疗 ,运用药物经济学的成本 -效果方法进行评价。结果 IVP组、MVP组和CAP组的成本 -效果比分别为 193 83、 14 6 3 9和 15 5 3 9。结论 从药物经济学的观点分析 。
Objective To evaluate the economical effectiveness of three differentchemotherapeutic schemes in treatment of late non small cell lung cancer(NSCLC).Methods Totally 93 cases of NSCLC were diveded into three groups and they were given three chemotherapeutic schemes respectively,IVP,MVP and CAP.The cost and efficacy of the schemes were analyzed according to pharmacoeconomic principles.Results The cost effect ratios of IVP,MVP and CAP treatment groups were 193 83,146 39 and 155 39 respectively.Conclusions MVP was considered as the best of the three chemotherapeutic schemes according to the overall evaluations.
出处
《华北国防医药》
2003年第2期85-86,共2页
Medical Journal of Beijing Military Region
关键词
晚期
非小细胞肺癌
化疗方案
成本-效果分析
药物疗法
Pharmacoeconomics
Cost effectiveness analysis
Carcinoma,non small cell,lung
Drug Therapy
